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Loss of XIAP facilitates switch to TNFα-induced
necroptosis in mouse neutrophils
Simone Wicki1, Ursina Gurzeler1, W Wei-Lynn Wong2, Philipp J Jost3, Daniel Bachmann1 and Thomas Kaufmann*,1
Neutrophils are essential players in the first-line defense against invading bacteria and fungi. Besides its antiapoptotic role, the
inhibitor of apoptosis protein (IAP) family member X-linked IAP (XIAP) has been shown to regulate innate immune signaling.
Whereas the role of XIAP in innate signaling pathways is derived mostly from work in macrophages and dendritic cells, it is not
known if and how XIAP contributes to these pathways in neutrophils. Here we show that in response to bacterial
lipopolysaccharides (LPS), mouse neutrophils secreted considerable amounts of tumor necrosis factor-α (TNFα) and interleukin-
1β (IL-1β) and, in accordance with earlier reports, XIAP prevented LPS-induced hypersecretion of IL-1β also in neutrophils.
Interestingly, and in contrast to macrophages or dendritic cells, Xiap-deficient neutrophils were insensitive to LPS-induced cell
death. However, combined loss of function of XIAP and cIAP1/-2 resulted in rapid neutrophil cell death in response to LPS. This cell
death occurred by classical apoptosis initiated by a TNFα- and RIPK1-dependent, but RIPK3- and MLKL-independent, pathway.
Inhibition of caspases under the same experimental conditions caused a shift to RIPK3-dependent cell death. Accordingly, we
demonstrate that treatment of neutrophils with high concentrations of TNFα induced apoptotic cell death, which was fully
blockable by pancaspase inhibition in wild-type neutrophils. However, in the absence of XIAP, caspase inhibition resulted in a shift
from apoptosis to RIPK3- and MLKL-dependent necroptosis. Loss of XIAP further sensitized granulocyte–macrophage colony-
stimulating factor (GM-CSF)-primed neutrophils to TNFα-induced killing. These data suggest that XIAP antagonizes the switch
from TNFα-induced apoptosis to necroptosis in mouse neutrophils. Moreover, our data may implicate an important role of
neutrophils in the development of hyperinflammation and disease progression of patients diagnosed with X-linked
lymphoproliferative syndrome type 2, which are deficient in XIAP.
Cell Death and Disease (2016) 7, e2422; doi:10.1038/cddis.2016.311; published online 13 October 2016
Neutrophil granulocytes mature in the bone marrow and are
released as terminally differentiated, short-lived cells into the
blood where they constitute the most abundant leukocyte
population in humans. Neutrophils are essential players in the
host defense against bacterial and fungal infections. They are
the first blood leukocytes to be recruited to sites of infection
and play a central role in the first-line innate immune defense.
Neutrophils express a large variety of surface receptors
including innate immune receptors to recognize invading
pathogens. Activation of those receptors leads to elimination
of pathogens by phagocytosis, secretion of granule contents,
reactive oxygen species and release of neutrophil extracellular
traps.1 Toll-like receptor-4 (TLR4), a receptor for bacterial
lipopolysaccharides (LPS), is one of the most important
receptors constitutively expressed by neutrophils,1,2 which
upon activation enhances activity, cell survival and proin-
flammatory cytokine secretion.2,3
Once activated at sites of inflammation, the lifespan of
neutrophils has to be tightly controlled to avoid collateral
damage to surrounding healthy tissue. Elimination of neu-
trophils is effectuated by apoptosis, whereas the exact
mechanisms are not fully understood. Recently, it has been
shown that neutrophils are eliminated by FAS/CD95 during
viral and bacterial infections.4 However, neutrophils are also
susceptible to other death receptors, in particular tumor
necrosis factor receptor-1 (TNF-R1).5–7 Defects in the intrinsic
(mitochondrial) apoptotic pathway prolong the lifespan of
neutrophils.8,9 Failure of neutrophils to undergo apoptosis
contributes to chronic inflammation and tissue destruction and
is found in various pathologies, such as rheumatoid arthritis,
cystic fibrosis and chronic obstructive pulmonary
disease.10–12
Members of the inhibitor of apoptosis protein (IAP) family
are important modulators of cell death and cellular
signaling.13,14 X-linked IAP (XIAP) has first been recognized
for its antiapoptotic function and it remains the only family
member that can directly block the catalytic activities of
caspase-3/-7 and, to lesser extent, caspase-9, via its
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baculoviral IAP repeat (BIR) domains.13,15 XIAP is a critical
discriminator between FAS/CD95-induced type I and type II
apoptotic signaling.16,17 In contrast to FAS/CD95, TNF-R1
does not typically induce cell death at physiological
concentrations in most cell types, but rather triggers strong
activation of NF-κB and subsequent transcription of proin-
flammatory and prosurvival genes. Depending on the cellular
context, however, TNF-R1 signaling can switch from NF-κB
activation to apoptosis or necroptosis, respectively.18–20
Ubiquitylation of RIPK1 favors NF-κB activation and in turn
survival, whereas deubiquitylation of RIPK1 proceeds to
complex II formation, which results either in caspase-
mediated apoptosis or RIPK3- and MLKL-mediated
necroptosis.19,21–23 In contrast to cIAP1/-2, which act as E3
ubiquitin ligases within proximal signaling complexes of death
receptors and certain TLRs (TLR2 and TLR4), XIAP has not
been directly implicated in TNF-R1 signaling and has never
been found within proximal signaling complexes I and
II.14,24–26 However, a role for XIAP in TNFα-induced cell
death, likely outside of complex I, has recently been shown in
macrophages and dendritic cells (DCs).27,28
Similar to cIAP1/-2, XIAP contains a RING domain that
functions as E3 ubiquitin ligase regulating NF-κB and MAPK
signaling pathways.14,29,30 The best example currently is the
positive regulation of NOD1/2-dependent signaling by XIAP
upon detection of intracellular bacteria.31–33 A crucial physio-
logical role of XIAP in immunity is supported by loss-of-
function mutations in patients suffering from the primary
immunodeficiency disorder X-linked lymphoproliferative
syndrome 2 (XLP2).34
The role of XIAP in innate immune signaling is almost
exclusively derived from work in macrophages and
DCs.27,28,35,36 To date, little is known about the function and
importance of XIAP in neutrophils, despite their prominence in
the blood and at sites of infection.11 Neutrophils are implicated in
several pathologies in which XIAP might have a role, including
rheumatoid arthritis or inflammatory bowel disease.27,37–39
Aberrant expression of XIAP (as well as cIAP1/-2) has been
reported in a variety of human cancers and is associated with
poor prognosis, chemoresistance and disease progression.40
Specific targeting of individual IAPs using small-molecule
inhibitors called Smac (second mitochondria-derived activator
of caspase) mimetics (or IAP inhibitors) constitutes a potential
promising novel therapeutic approach.41
Here, we determined the role of XIAP in response to LPS
and subsequent TNFα4TNF-R1 signaling in mouse neutro-
phils. We observed that XIAP largely maintains viability of
LPS-stimulated neutrophils when cIAP1/-2 are inhibited.
However, additional loss of XIAP resulted in rapid cell death
via TNFα- and RIPK1-dependent apoptosis. We show that
mouse neutrophils were intrinsically sensitive to caspase-
dependent apoptosis in response to high TNFα and that a
switch to necroptosis did not occur when caspases were
blocked, despite high expression levels of RIPK1, RIPK3 and
MLKL. However, loss of XIAP promoted a shift towards
necroptosis. These results implicate a previously unrecog-
nized direct regulatory role of XIAP downstream of TNF-R1 in
neutrophils.
Results
LPS induces production of TNFα in mouse neutrophils
and exacerbated IL-1β release upon loss of XIAP. We first
assessed viabilities over time and cytokine production of wild-
type (WT) and Xiap-deficient (henceforth termed Xiap− /−)
neutrophils stimulated with ultrapure LPS. Besides primary
neutrophils isolated from bone marrow, which can only be
obtained in limited numbers, neutrophils were differentiated
in vitro using conditional Hoxb8, which is a suitable tool for
the generation of large quantities of functional mouse
neutrophils.42–45 LPS did not increase cell death in primary
or in vitro differentiated WT neutrophils but induced the
release of TNFα and IL-6, which was further enhanced
upon priming with GM-CSF (Figures 1a, b and
Supplementary Figures S1a–d). LPS induced comparable
TNFα and IL-6 levels in Xiap− /− neutrophils, but, interestingly,
loss of XIAP did not increase cell death, in contrast to
previous reports on macrophages and DCs.27,28 It has
been shown for macrophages and DCs that in the absence
of XIAP, or alternatively cIAP1/-2, LPS stimulation alone
causes exacerbated IL-1β secretion.28,35 Consistent with
these findings, GM-CSF priming followed by LPS stimulation
promoted excessive IL-1β secretion in Xiap− /−, but not in WT,
neutrophils that was preceded by proteolytic processing of
procaspase-8 (Figures 1b, d, e and Supplementary Figures
S1b–d and f). However, LPS stimulation induced comparable
levels of pro-IL-1β and NLRP3 in both genotypes, and this
was further enhanced by GM-CSF (Supplementary
Figure S1e). IL-1β secretion was abrogated upon additional
loss of Ripk3 (Figure 1b). Furthermore, additional loss of
caspase-1/-11 in Xiap− /− neutrophils partially reduced but
did not completely abolish IL-1β secretion (Supplementary
Figure S1b), which is consistent with findings in DCs.28
Interestingly, LPS induced a rapid decrease in RIPK1 in WT
neutrophils, which was less prominent in Xiap− /− neutrophils
(Figures 1c and e). This decrease of RIPK1 was not
prevented upon neutralizing TNFα or blocking apoptotic
caspases (Supplementary Figure S1g). Immunoblot analysis
showed that both unprimed and primed mouse neutrophils
express readily detectable levels of RIPK1, RIPK3 and MLKL,
all of which are necessary for a cell to undergo necroptotic
cell death (Figures 1c–e). Proteasomal inhibition using
bortezomib induced a mobility shift but did not restore RIPK1
protein levels (Figure 1f). Taken together, LPS-stimulated
Xiap− /− neutrophils secrete comparable levels of TNFα
compared with WT cells, but massively increased levels of
IL-1β upon priming. Furthermore, XIAP seems to regulate the
stability of RIPK1 in response to LPS.
LPS kills cIAP1/-2-depleted neutrophils in a TNFα-
dependent manner only upon additional loss of XIAP. To
assess the involvement of XIAP in the regulation of TLR4
signaling in neutrophils, we used the monovalent Smac
mimetic AT-406, which, despite its ability to bind to all three
IAPs, predominantly antagonizes cIAP1/-2 (cIAP1,
Ki= 1.9 nM; cIAP2, Ki= 5.1 nM; XIAP, Ki=66.4 nM),
46 and
the bivalent Smac mimetic compound A (Cp.A) with high
binding affinity to XIAP and cIAP1/-2.47 In contrast to
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macrophages,48 treatment of WT and Xiap− /− neutrophils
with Smac mimetics alone did not elicit any detectable
secretion of TNFα or IL-1β (Figure 2a and Supplementary
Figure S2a). Whereas AT-406 did not induce cell death in WT
neutrophils, a small but significant increase in cell death was
observed in Xiap− /− neutrophils as well as in Cp.A-treated
WT neutrophils (Figure 2b). This cell death could be blocked
by TNFα neutralization (Enbrel) (Figure 2c). Importantly,
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stimulation with LPS had a massive negative impact on
viability when the function of all IAPs was lost. Whereas
AT-406-treated WT neutrophils were refractory to killing by
LPS, the same treatment in Xiap− /− neutrophils induced
complete cell death within 24 h, as did Cp.A plus LPS
in WT neutrophils (Figure 2b and Supplementary
Figure S2b). To test the contribution of TNFα or IL-1β to the
observed cell death, we pre-treated the cells with Enbrel or an
IL-1β receptor antagonist (Anakinra). As shown in
(Figures 2d, e and Supplementary Figure S2c), blocking of
IL-1R had no impact on cell viability, whereas antagonism of
TNFα almost completely abolished cell death. Taken
together, only loss of all three IAP sensitizes neutrophils to
LPS-induced killing, which depends on TNFα but is
independent of IL-1β. Furthermore, the data show that
XIAP crucially controls survival of LPS-stimulated neutro-
phils, as it fully maintains viability when cIAP1/-2 are
functionally lost.
LPS induces RIPK1-dependent apoptosis in IAP-depleted
neutrophils. To investigate the type of TNFα-dependent cell
death induced by LPS plus Smac mimetics (Figure 2), we
analyzed proteolytic processing of apoptotic caspases in WT
and Xiap− /− neutrophils by immunoblotting. Cotreatment of
AT-406 with LPS induced rapid and strong proteolytic
cleavage of procaspase-8 and -3 into their putatively active
forms in Xiap− /− but, importantly, not in WT neutrophils
(Figure 3a). Coaddition of LPS and Cp.A also led to a strong
cleavage of caspases; however, this was now comparable
between the two genotypes (Figure 3b). Furthermore,
caspase-8 processing correlated with a decrease of its
substrates RIPK1 and RIPK3. Cleavage of effector caspase
substrate PARP concurred with the processing of procas-
pase-3, suggesting that this caspase was indeed active
(Figure 4b). Enzymatic activation of caspases-3/-7 was
confirmed by fluorogenic (DEVDase) assay. Upon treatment
of Xiap− /− neutrophils with AT-406 plus LPS, or WT or
Xiap− /− neutrophils with Cp.A plus LPS, caspase-3/-7 was
activated within 1 h and peaked after 6–8 h (Figures 3c and
d). Importantly, caspase-3/-7 activation was dependent on
the enzymatic activity of RIPK1, as its specific inhibitor
necrostatin-1 (Nec.1) blocked DEVDase activity (Figure 4a),
processing of procaspases and the decrease of RIPK1 and
RIPK3 (Figure 4b). Nec.1 consequently inhibited LPS-
induced cell death in IAP-depleted neutrophils (Figure 4e).
In accordance with our previous observation that the
observed cell death was TNFα dependent, necrostatin-1
blocked LPS-induced de novo production and release of
TNFα (Figures 4c and d).
Interestingly, whereas Nec.1 was highly efficient in prevent-
ing LPS plus Smac mimetics-induced cell death in WT or
Xiap− /− neutrophils, addition of the pancaspase inhibitor
Q-VD-OPh had no protective effect (Figure 4e). Genetic loss
of Ripk3 did not prevent cell death by LPS plus Smac
mimetics. However, on a Ripk3− /− genetic background,
pancaspase inhibition now fully protected the cells under
these experimental conditions (Figures 4f and g). When IAP-
depleted neutrophils were stimulated with LPS, Q-VD-OPh
induced the translocation of the RIPK3 substrate and
critical effector molecule of necroptosis, MLKL, from a soluble
(aqueous) fraction to an integral membrane-enriched
(detergent) fraction (Figure 4h). Collectively, these data
indicate that XIAP is crucial in maintaining neutrophil viability
in response to LPS and that in the absence of all three IAPs,
rapid caspase-dependent apoptosis is initiated, which
depends on RIPK1 activity and requires autocrine TNFα but
is independent of RIPK3. Blocking of caspases may then shift
the cell death from apoptosis to RIPK3- and MLKL-dependent
necroptosis.
XIAP blocks the switch from TNFα-induced apoptosis to
necroptosis in mouse neutrophils. Based on the obtained
importance of TNFα in LPS plus Smac mimetics-induced
neutrophil cell death, we next studied the role of XIAP
downstream of TNF-R1. As reported previously, low concen-
trations of TNFα promote survival, whereas high doses
induce apoptosis in neutrophils. Consistent with previous
reports,5,7 both primary and in vitro differentiated WT
and Xiap− /− neutrophils underwent significantly increased
cell death in response to high concentrations of TNFα
(Figure 5a and Supplementary Figure S3a). Furthermore,
sensitivity to lower concentrations (10 and 1 ng/ml, respec-
tively) of TNFα was strongly increased upon treatment
with Smac mimetics (Supplementary Figures S3c and d).
TNFα-induced cell death occurred by apoptosis, as assessed
by the processing of caspase-8, activation of caspase-3 and
PARP cleavage (Figures 5b–d and Supplementary
Figure S3b). Importantly, pancaspase inhibition could fully
rescue TNFα-induced cell death in WT neutrophils but
had only minimal protective effects in Xiap− /− neutrophils
(Figure 5a and Supplementary Figure S3a). Complete
protection in Xiap− /− neutrophils could only be achieved
upon combined inhibition of caspases and RIPK1 or MLKL,
respectively (Figures 5a, e and Supplementary Figure S3a).
These data indicate that while caspase inhibition fails to
convert TNFα-induced apoptosis to necroptosis in
WT neutrophils, such a switch does occur upon loss of XIAP.
In support of this model, Ripk3− /−Xiap− /− neutrophils were
equally sensitive as Xiap− /− neutrophils to TNFα-induced
killing, but this cell death was now fully blockable by Q-VD-
OPh (Figure 5f). Furthermore, increased amounts of MLKL
translocated to an integral membrane-enriched fraction
Figure 1 Loss of XIAP results in excessive secretion of IL-1β in the absence of increased cell death and stabilization of RIPK1. (a) Assessment of viability in WTand Xiap− /−
neutrophils upon treatment with LPS (100 ng/ml) for indicated time points; n≥ 6, mean± S.E.M. (b) WT, Xiap− /−, Ripk3− /− and Ripk3− /−Xiap− /− neutrophils were treated with
LPS (100 ng/ml) for 24 h, and supernatants were assessed for TNFα, IL-6 and IL-1β by ELISA; n≥ 3, mean±S.E.M. (c and d) Unprimed and (e) GM-CSF-primed (1 ng/ml for
30 min) WTand Xiap− /− neutrophils were stimulated with LPS (100 ng/ml) for 0–8 h, and lysates were subjected to quantitative immunoblot using near-infrared fluorescence.
Presented immunoblots are representative of at least two independent experiments. *Nonspecific band. (f) WT and Xiap− /− neutrophils were pre-treated for 30 min with
bortezomib (1 and 10 μM), and stimulated with LPS (100 ng/ml) for 3 and 6 h. Lysates were assessed by immunoblot. Presented immunoblots are representative of at least two
independent experiments. All experiments were performed with in vitro differentiated neutrophils. *Po0.05, **Po0.01, ***Po0.005, ****Po0.001
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in TNFα plus Q-VD-OPh-stimulated Xiap− /− neutrophils
(Figure 5g). Taken together, our data show that high
concentrations of TNFα elicit apoptosis in both WT and
Xiap− /− neutrophils. However, a switch to necroptosis upon
inhibition of caspases does not occur in WT neutrophils but is
enabled when XIAP is lost.
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Loss of XIAP sensitizes GM-CSF-primed neutrophils
towards TNFα-induced cell death. Priming with the proin-
flammatory cytokine GM-CSF strongly protected primary and
in vitro differentiated WT and Xiap− /− neutrophils from
spontaneous apoptosis (Figure 6a and Supplementary
Figure S4a). Notably, whereas primed WT neutrophils were
now refractory to high concentrations of TNFα, primed
Xiap− /− neutrophils remained sensitive to TNFα-induced
killing (Figures 6a, b and Supplementary Figure S4a).
Interestingly, GM-CSF priming increased expression levels
of XIAP (Figure 6c and Supplementary Figure S1e). Further-
more, loss of XIAP resulted in increased ubiquitylation of
RIPK1 and, to lesser extent, also of RIPK3 (Figure 6d).
Whereas reconstitution of Xiap− /− neutrophils with full-length
XIAP restored resistance to TNFα-induced killing, expression
of both BIR2 (XIAP L207P and XIAP C203Y) and RING
Figure 2 LPS kills cIAP1/-2-depleted neutrophils in a TNFα-dependent manner only upon additional loss of XIAP. (a) Supernatants were collected from WTand Xiap− /−
neutrophils pre-treated with AT-406 (1 μM) or Cp.A (500 nM) for 30 min as indicated and stimulated with LPS for 24 h. TNFα and IL-1β in the supernatants were measured by
ELISA; n≥ 3, mean± S.E.M. (b) Assessment of viability of WTand Xiap− /− neutrophils pre-treated with AT-406 (1 μM) or Cp.A (500 nM) for 30 min and subsequently stimulated
with LPS (100 ng/ml) for indicated time points; n≥ 6, mean±S.E.M. (c and d) WT and Xiap− /− neutrophils were pre-treated with TNF antagonist (10 μg/ml) for 30 min,
incubated with (c) AT-406 (1 μM) or Cp.A (500 nM) and stimulated with (d) LPS (100 ng/ml) for indicated time points. Viability was assessed by flow cytometry; n≥ 3, mean± S.E.
M. (e) WTand Xiap− /− neutrophils were pre-treated with IL-1R antagonist (10 μg/ml) for 30 min, further incubated with AT-406 (1 μM) or Cp.A (500 nM) and stimulated with LPS
(100 ng/ml) for indicated time points. Viability was assessed by flow cytometry; n≥ 3, mean± S.E.M. All experiments were performed with in vitro differentiated neutrophils. Same
data sets of untreated control and Smac mimetics (SM)± LPS are shown in the different subpanels. *Po0.05, **Po0.01, ***Po0.005, ****Po0.001
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were performed with in vitro differentiated neutrophils. *Po0.05, **Po0.01, ***Po0.005
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domain (XIAP G466stop and XIAP P482R) mutants failed to
rescue the cell death phenotype (Figures 6e and f). These
data show that XIAP contributes to maintaining the viability of
neutrophils under inflammatory conditions and indicate that
both the BIR2 and the RING domain of XIAP are critical for
the negative regulation of TNFα-induced cell death.
XIAP regulates TNFα-induced neutrophil death
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Discussion
Besides its first identified role as direct caspase inhibitor, XIAP
has recently been implicated in a RING domain-dependent
positive regulation of NOD1/2 signaling in response to
intracellular bacteria and in restriction of RIPK3-dependent
cell death and inflammasome activation downstream of TNF-
R1 and TLR4.28,31,33,35 Most of these data are derived from
macrophages or DCs. To date, little is known about the role of
XIAP in innate signaling of neutrophils, which constitute a
central first-line defense against invading pathogens, in
particular bacteria and fungi. We therefore focused our study
on LPS4TLR4- and TNFα4TNF-R1-mediated signaling and
demonstrate a pivotal role of XIAP in regulating proinflamma-
tory and cell death signaling in mouse neutrophils. In
agreement with previous reports,8,49 we show that neutrophils
can secrete significant amounts of IL-1β. We show for the first
time in neutrophils that, similar to macrophages and DCs,27,35
loss of XIAP also promotes excessive IL-1β secretion in
response to LPS (Figure 1). IL-1β secretion depended on
RIPK3 and partly on caspase-1/-11, and based on the
proteolytic activation of caspase-8 may additionally involve
caspase-8-mediated processing of pro-IL-1β, as reported
previously.35 In contrast to macrophages and DCs, however,
neutrophils were shown to secrete IL-1β without undergoing
pyroptosis.49 These data suggest that Xiap− /− neutrophils
may contribute to hyperinflammation and progression in
certain pathologies seen in X-linked lymphoproliferative
syndrome 2 patients. On the same line, mice lacking IAPs,
including XIAP, may critically contribute to the immunopatho-
genesis observed in arthritis or during γ-herpesvirus
infection.27,28
Macrophages and certain tumor cells die in response to
single treatment with Smac mimetics through NF-κB- and
autocrine TNFα4TNF-R1-dependent cell death.48,50,51 Intri-
guingly, Smac mimetics showed only weak killing potential
per se on neutrophils and only when all three IAPs were
targeted. Interestingly, this cell death was TNFα-dependent
despite very low (or non-detectable) levels of soluble TNFα in
the supernatants (Figure 2). This may suggest a role for
membrane-bound TNFα in Smac mimetics-induced killing of
neutrophils, which needs further investigations. Importantly,
however, upon combined loss of all three IAPs, but not when
XIAP was expressed, LPS stimulation resulted in increased
TNFα secretion and markedly increased TNFα-dependent cell
death. Our data demonstrate that this cell death occurs by
classical apoptosis, and results in cleavage of the caspase-8
substrates RIPK1 and RIPK3 (Figures 3 and 4). Blockage of
the enzymatic activity of RIPK1 by Nec.1 abolished caspase
activation. This implicates that neutrophils undergo RIPK1-
dependent apoptosis, similar to previous reports on other cell
types.48,52 Active RIPK1 is further critical for Smac mimetics-
induced transcriptional induction of TNFα in macrophages.48
Similarly, Nec.1 blocked Tnfα production in LPS plus Smac
mimetic-treated mouse neutrophils (Figure 4).
In agreement with the findings from LPS plus Smac
mimetics treatment, direct addition of high concentrations of
TNFα significantly increased cell death in both WT and
Xiap− /− neutrophils. It is worth discussing that unprimed
Xiap− /− neutrophils were not generally more sensitive than
WT controls, arguing that a direct blocking of effector
caspases by XIAP is inefficient to delay TNF-R1-mediated
apoptosis in neutrophils (Figure 5). Targeting of cIAP1/-2, but
not loss of XIAP, strongly sensitized neutrophils to lower
concentrations of TNFα, indicating that cIAP1/-2 are important
to prevent neutrophil cell death induced by low TNFα. Through
its inhibitory action on activated effector caspases, XIAP has
been shown to critically delay FasL/CD95L-induced apoptosis
in type II cells, such as hepatocytes or pancreatic β-cells.16
Mouse neutrophils were reported to show type II character-
istics in response to FasL/CD95L, but not in response to
TNFα.7,8 Importantly, we show that TNFα induces apoptosis in
WTand Xiap− /− neutrophils. However, in contrast to WT cells,
this cell death could not be blocked in Xiap− /− neutrophils
using Q-VD-OPh unless RIPK1 or MLKL were also inhibited or
RIPK3 was lost genetically. This implicates that in the absence
of XIAP, caspase inhibition shifts TNFα-induced apoptosis to
necroptosis. These findings are supported by our observation
that MLKL translocated to the membrane under these
conditions (Figure 5). It is somehow surprising that, despite
high expression levels of RIPK1, RIPK3 and MLKL proteins at
steady state (Figures 1 and 5), TNFα-treated WT neutrophils
do not switch to necroptotic cell death under caspase-blocking
conditions. Such a switch did, however, occur when XIAP was
lost. Interestingly, loss of XIAP resulted in a further increase of
RIPK1, RIPK3 and MLKL levels (Figure 5). Increased
ubiquitylation of RIPK1 and RIPK3 was detected in TNFα-
treated Xiap− /− neutrophils, implying a role of XIAP in
regulating stability and ubiquitylation status of those kinases
Figure 4 LPS plus Smac mimetics induces RIPK1-dependent apoptosis that switches to necroptosis upon caspase inhibition. (a) WT and Xiap− /− neutrophils were pre-
treated with Nec.1 (20 μM) for 30 min, AT-406 (1 μM) or Cp.A (500 nM) for 30 min and subsequently incubated with LPS (100 ng/ml) for 3 and 6 h. Lysates were assayed for
caspase-3/-7 activity; n≥ 4, mean± S.E.M. (b) WTand Xiap− /− neutrophils were pre-treated with Nec.1 (20 μM, 30 min) or Q-VD-OPh (20 μM, 30 min), then with either AT-406
(1 μM) or Cp.A (500 nM), and incubated with LPS (100 ng/ml) for 6 h. Lysates were assayed by immunoblot. Presented immunoblots are representative of at least two
independent experiments. (c) qPCR analysis of Tnfα in WTand Xiap− /− neutrophils pre-treated with Nec.1 (20 μM, 30 min) followed by either AT-406 (1 μM) or Cp.A (500 nM),
for another 30 min and stimulated with LPS (100 ng/ml) for 4 h. Hprt was used as reference gene; n= 3, mean±S.E.M. (d) WTand Xiap− /− neutrophils were preincubated with
Nec.1 (20 μM, 30 min), treated with either AT-406 (1 μM) or Cp.A (500 nM) and stimulated with LPS (100 ng/ml) for 6 h. Supernatants were analyzed for TNFα by ELISA; n≥ 4,
mean± S.E.M. (e) WTand Xiap− /− neutrophils were pre-treated with Q-VD-OPh (20 μM) or Nec.1 (20 μM) for 30 min, treated with AT-406 (1 μM) or Cp.A (500 nM) for 30 min
and subsequently stimulated with LPS (100 ng/ml) for different time points. Viability was determined by flow cytometry; n≥ 3, mean±S.E.M. Data sets of untreated control from
Figure 1a and SM+LPS from Figure 2b are included. (f) Ripk3− /− and (g) Ripk3− /−Xiap− /− neutrophils were pre-treated with Q-VD-OPh (20 μM) for 30 min, incubated with Cp.
A (500 nM) or AT-406 (1 μM), respectively, and stimulated with LPS (100 ng/ml) for indicated time points. Viability was assessed by flow cytometry; n≥ 3, mean± S.E.M. (h) WT
and Xiap− /− neutrophils were pre-treated with Q-VD (20 μM) for 30 min followed by administration of Cp.A (500 nM) or AT-406 (1 μM), respectively, for 30 min and stimulated
with LPS for 6 h. Fractionation by phase separation was performed and lysates were assayed by quantitative immunoblot. Presented immunoblots are representative of at least
two independent experiments. All experiments were performed with in vitro differentiated neutrophils. *Po0.05, **Po0.01, ***Po0.005, ****Po0.001
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(Figure 6). Our findings support the report by Yabal et al.28 in
which XIAP was shown to limit necroptosis of DCs by
regulating the stability of RIPK1 and RIPK3. Increased levels
and ubiquitylation of RIPK1, RIPK3 and MLKL may, at least in
part, explain the increased tendency of Xiap− /− neutrophils to
enter necroptosis. How XIAP regulates RIPK1 and RIPK3 is
still under investigation. As loss of cIAP1/-2 causes a
decrease in ubiquitylation of RIPK1,25 these findings point
XIAP regulates TNFα-induced neutrophil death
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towards an indirect ubiquitylation of a yet unknown target
protein by XIAP.
Further evidence for the involvement of XIAP in regulating
TNF-R1 signaling were obtained upon GM-CSF priming,
which mimics a proinflammatory environment and is known to
increase the lifespan and activity of neutrophils.3 In agree-
ment, primed WT neutrophils were protected from sponta-
neous apoptosis, which occurs through the mitochondrial
apoptotic pathway.9 GM-CSF priming also conferred resis-
tance to TNFα-induced cell death, even at high concentra-
tions. In sharp contrast, Xiap− /− neutrophils were protected
from spontaneous apoptosis but remained sensitive to high
TNFα. The finding that GM-CSF increased XIAP levels further
supports a role of XIAP in survival of neutrophils. This
phenotype could only be rescued upon re-expression of WT,
but not BIR2 or RING domain mutants of XIAP in a Xiap− /−
genetic background. It is conceivable to hypothesize that the
BIR2 domainmay be needed for binding and the RING domain
for ubiquitylation of a potential target protein, similar to reports
on NOD signaling.31 These findings place XIAP as important
negative regulator of TNFα-induced cell death under inflam-
matory conditions.
In summary, we have identified XIAP as an important
downstream regulator of TNFα-induced cell death in mouse
neutrophils. Loss of XIAP facilitates the switch from
LPS4TNFα-induced apoptosis to RIPK3-dependent necrop-
tosis and, importantly, also sensitizes GM-CSF-primed neu-
trophils to killing by TNFα. Furthermore, Xiap− /− neutrophils
secrete excessive amounts of IL-1β in response to LPS. Given
the abundance of neutrophils at sites of infection and their
essential role in early innate immune defense against invading
pathogens, these findings may have direct implications to
immunopathologies that are associated with loss-of-function
mutations in XIAP, such as X-linked lymphoproliferative
syndrome 2 (XLP2). The data further underline that unspecific
targeting of IAP may cause unwanted side effects by
compromising neutrophil viability.
Materials and Methods
Mice and reagents. C57BL/6 mice were maintained under pathogen-free
conditions in IVC cages. Xiap− /−53 and Ripk3− /− mice54 both backcrossed onto
the C57BL/6 genetic background for at least eight generations, and Xiap− /−
Ripk3− /− mice (from P Jost), have been described previously.28 Animal
experiments were approved by the animal experimentation review board of the
canton of Bern (BE31/11 and BE12/14).
RPMI-1640 AQmedia, 4-hydroxytamoxifen (4-OHT) and propidium iodide were
purchased from Sigma-Aldrich Chemie GmbH (Buchs, Switzerland). Fetal calf serum
(FCS; Sera Pro, ultra-low endotoxin) was purchased from Pan Biotech (Aidenbach,
Germany). 2-Mercaptoethanol (2-ME) and penicillin/streptomycin were from Life
Technologies (Carlsbad, CA, USA). CHO/SCF (mm) conditioned medium was used
as a source of mouse stem cell factor and was produced as described previously.45
Recombinant FLAG-TNFα (mouse) and necrostatin-1 were purchased from Enzo
LifeSciences AG (Lausen, Switzerland). AT-406 was from SelleckChem (Houston, TX,
USA). Q-VD-OPh was purchased from SM Biochemicals (Anaheim, CA, USA).
GW806742X was from Synkinase (Parkville, VIC, Australia). Recombinant mouse
GM-CSF was from Peprotech (Rocky Hill, NJ, USA). Ultrapure LPS (E. coli K12) and
ATP were from Invivogen (San Diego, CA, USA). Anti-TNF (Enbrel) was a kind gift
from P Jost (Munich, Germany). IL-1 receptor antagonist (Anakinra) was a kind gift
from P Villiger (Bern, Switzerland). Cp.A (GT12911) was produced by TetraLogic
Pharmaceuticals (Malvern, PA, USA). Recombinant His6-tagged GFP-Annexin V was
purified as described previously.55 Cherry-Annexin V was purified in-house. Agarose-
TUBE1 (tandem-ubiquitin binding entity 1) was from LifeSensors (Malvern, PA, USA).
In vitro differentiation of mouse neutrophils. Conditional Hoxb8
immortalized neutrophil/macrophage committed myeloid progenitors, termed
SCF-condHoxb8 cells, were generated from bone marrow of WT, Xiap− /−, Ripk3− /
− and Xiap− /−Ripk3− /− mice as described previously.45,56 The cells were cultivated
in RPMI-1640 AQmedia supplemented with 10% FCS, 1% penicillin/streptomycin, 5%
SCF and 0.1 μM 4-OHT. Mature neutrophils were obtained within 5 days upon
removal of 4-OHT from the medium. To confirm differentiation, neutrophils were
stained for the surface marker profile Gr-1(Ly-6C/Ly-6G)hiCD11b+CD117(c-kit)neg,
using the following antibodies (all from BioLegend, San Diego, CA, USA): rat anti-Gr-1
(clone RB6-8C5), rat anti-CD11b (clone M1/70) and rat anti-CD117 (c-kit, clone 2B8).
All experiments were performed with mature neutrophils.
Generation of Xiap− /− SCF-condHoxb8 neutrophils with recon-
stituted XIAP mutants. cDNAs of 3xHA-XIAP WT, the RING mutants, 3xHA-
XIAP(G466stop) and 3xHA-XIAP(P482R), and the BIR2 mutants, 3xHA-XIAP
(C203Y) and 3xHA-XIAP(L207P) (kind gift from M Gyrd-Hansen, Oxford, UK), were
subcloned into the CAD-G-Whiz lentiviral expression vector, carrying an IRES-EGFP
element,57 and subsequently transduced into Xiap− /− SCF-condHoxb8 neutrophil
progenitors. As a negative control, empty CAD-G-Whiz lentiviral expression vector
was transduced into Xiap− /− SCF-condHoxb8 neutrophil progenitors.
Isolation of primary Gr-1+ neutrophils from bone marrow. Bone
marrow cells were harvested from femoral bones. Gr-1+ cells were isolated by
magnetic bead-based cell sorting according to the manufacturer’s instructions (BD
IMag; BD Biosciences, San Jose CA, USA) and using rat anti-Gr-1 (clone RB6-8C5)
antibody from BioLegend. Cytospins of isolated neutrophils were stained with
DiffQuik solution (Baxter, Deerfield IL, USA) and the morphology was checked
under the light microscope. The purity was routinely above 95%. Isolated
neutrophils were cultivated in RPMI-1640 AQmedia supplemented with 10% FCS,
1% penicillin/streptomycin and 50 μM 2-ME.
Assessment of cell death by flow cytometry. Neutrophils were stained
with GFP-Annexin V or Cherry-Annexin V diluted in FACS buffer (150 mM NaCl,
4 mM KCl, 2.5 mM CaCl2, 1 mM MgSO4, 15 mM HEPES (pH 7.2), 2% FCS and
10 mM NaN3) for 20 min on ice in the dark. Cells were washed once with FACS
buffer and resuspended in FACS buffer containing 2 μg/ml of propidium iodide. Cells
were analyzed by flow cytometry (FACSCalibur; BD Biosciences) and data were
Figure 5 XIAP prevents Q-VD-OPh induced shift from apoptosis to necroptosis in response to high concentrations of TNFα in neutrophils. (a and e) WT and Xiap− /−
neutrophils were pre-treated with Q-VD-OPh (20 μM) and (a) Nec.1 (20 μM) or (e) the MLKL inhibitor GW806742X (1 μM) for 30 min and subsequently stimulated with
recombinant TNFα (100 ng/ml) for indicated time points. Viability was assessed by flow cytometry; n≥ 4, mean±S.E.M. Same data sets of TNF±Q-VD treatments are shown in
(a and e); data sets of untreated control from Figure 1a are included in (e). (b) WTand Xiap− /− neutrophils were stimulated with TNFα (100 ng/ml) for 16 and 24 h. Lysates were
assayed by immunoblot. Presented immunoblots are representative of at least two independent experiments. (c) WTand Xiap− /− neutrophils were treated with TNFα (100 ng/ml)
for 24 h. Cells were stained for active caspase-3/-7 (green) using CellEvent Caspase-3/-7 Green Detection Reagent and PI (red). Presented images are representative of at least
two independent experiments. Additionally, stained cells were analyzed by flow cytometry. (d) WTand Xiap− /− neutrophils were treated with TNFα (100 ng/ml) for 16 and 24 h.
Lysates were assayed for caspase-3/-7 activity using fluorogenic DEVDase assay; n≥ 3, mean±S.E.M. (f) Ripk3− /−Xiap− /− neutrophils were preincubated with Q-VD-OPh
(20 μM) and further stimulated with TNFα (100 ng/ml) for indicated time points. Viability was assessed by flow cytometry; n≥ 6, mean±S.E.M. Data set of untreated control
from Figure 4g is included to facilitate comparison. (g) WT and Xiap− /− neutrophils were pre-treated with Q-VD-OPh (20 μM) for 30 min followed by administration of TNFα
(100 ng/ml) for 16 h. Fractionation by phase separation was performed and lysates were assayed by quantitative immunoblot. Presented immunoblots are representative of at
least two independent experiments. All experiments were performed with in vitro differentiated neutrophils. *Po0.05, **Po0.01, ***Po0.005, ****Po0.001
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analyzed using WEASEL version 3.0.2. Cells negative for both GFP-Annexin V and
propidium iodide were considered as viable.
Gel electrophoresis and immunoblotting. Cells were lysed in IBC
buffer (10 mM Tris-HCl, 1 mM EGTA, 200 mM sucrose, 2 mM MgCl2, 1% CHAPS,
complemented with protease inhibitors (Roche Complete protease inhibitor cocktail
plus 1 μg/ml pepstatin), pH 7.6) where indicated or directly lysed in hot H8 buffer
(20 mM Tris-HCl (pH 7.5), 2 mM EGTA, 2 mM EDTA, 1% SDS, supplemented with
50–100 mM DTT). Proteins from supernatants were precipitated as described
previously.58 Proteins were denatured by adding 4 × Laemmli buffer (supplemented
with 100 mM DTT) and boiling for 5 min. Proteins were separated on 7.5–15%
denaturing SDS-PAGE gels and transferred to PVDF membrane (Immobilon-FL,
0.45 μM; Merck Millipore, Zug, Switzerland) for detection. Membranes were
probed overnight with the following primary antibodies: rabbit polyclonal anti-RIPK3
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(ProSci, Poway, CA, USA; no. 2283); mouse anti-GAPDH (clone 6C5; Merck
Millipore); mouse anti-RIPK1 (clone 610458), mouse anti-XIAP (clone 28/hILP/XIAP),
mouse anti-PARP (clone C2-10) and mouse anti-actin (C4/actin) from BD
BioSciences; rat anti-MLKL (clone 3H1, a kind gift from WS Alexander, Melbourne,
VIC, Australia); rat anti-procaspase-8 (clone 1G12, a kind gift from L O’Reilly,
Melbourne, VIC, Australia); rabbit anticleaved-caspase-8 (clone D5B2), rabbit
polyclonal anti-procaspase-3 (no. 9662) and anticleaved-caspase-3 (no. 9661) from
Cell Signaling (Danvers, MA, USA); rat anti-cIAP1 (clone 1E1-1-10, Enzo
LifeSciences); mouse anti-porin (clone 89-173/016) from Calbiochem (Merck Millipore,
Schaffhausen, Switzerland); mouse anti-tubulin (clone B-5-1-2) from Sigma (Buchs,
Switzerland); rat anti-HA high affinity (clone 3F10) from Roche (Rotkreuz, Zug,
Switzerland); mouse anti-NLRP3/NALP3 (clone Cryo-2, a kind gift from H-U Simon,
Bern, Switzerland); rat anti-IL-1β (clone 166926; R&D, Bio-Techne, Minneapolis, MN,
USA); rabbit anti-caspase-1 (clone EPR4321; Abcam, Cambridge, MA, USA). For
TUBE1 purification assay and fractionation by phase separation experiments,
secondary antibodies conjugated to horseradish peroxidase (Jackson ImmunoR-
esearch Europe Ltd, Newmarket SFK, UK) were used and signals were obtained by
enhanced chemiluminescence (Luminata Forte Western HRP substrate; Merck
Millipore). For all immunoblots with total lysates, infrared dye-conjugated secondary
antibodies (LI-COR Biosciences, Bad Homburg, Germany) were used. All
immunoblots were analyzed with the Odyssey Fc Dual-Mode Imaging System using
the ImageStudio software 3.1.4 (LI-COR Biosciences).
TUBE1 purification. A total of 3–4 × 107 neutrophils were stimulated as
indicated and lysed in 3 ml IBC buffer (10 mM Tris-HCl, 1 mM EGTA, 200 mM
sucrose, 2 mM MgCl2, 1% CHAPS, complemented with protease inhibitors (Roche
Complete protease inhibitor cocktail plus 1 μg/ml pepstatin), pH 7.6) for 30 min on
ice. Lysates were cleared by centrifugation and ubiquitylated proteins were captured
overnight at 4 °C on a rotating wheel using agarose-TUBE1, which displays a
10-fold higher affinity for K63-ubiquitylated proteins compared with K48-ubiquitylated
proteins (LifeSensors, Malvern PA, USA). Beads were washed four times with IBC
buffer and boiled for 5 min in 1 × Laemmli buffer containing 100 mM DTT.
Cytokine ELISA. Mouse-specific IL-1β, IL-6 and TNFα ELISA Kits were from
BioLegend and cytokine levels in cellular supernatants were measured according to
the manufacturer’s instructions.
Detection of active caspase-3 and -7. A total of 2–4 × 105 neutrophils
were treated with 100 ng/ml of TNFα for indicated time points. Active caspase-3
and -7 were stained using CellEvent Caspase-3/7 Green Detection Reagent
(Invitrogen, Thermo Fisher Scientific, Waltham, MA, USA) according to the
manufacturer’s instructions. Signals were acquired with a Zeiss AxioObserver.Z1
fluorescence microscope (Zeiss, Oberkochen, Germany) and by flow cytometry
(FACSCalibur; BD BioSciences).
As a second approach, caspase-3 and -7 enzymatic activity was quantified by
fluorometric assay using DEVD-AMC as a substrate (Bachem, Bubendorf, Switzerland).
A total of 1 × 106 neutrophils were lysed in 50 μl digitonin lysis buffer (20 mM HEPES
(pH 7.4), 100 mM sucrose, 25 mM MgCl2, 100 mM KCl, protease inhibitor cocktail
(RocheComplete protease inhibitor cocktail plus 1 μg/ml pepstatin), 1 mMDTT, 0.025%
digitonin). Assay buffer (0.1 M HEPES (pH 7.5), 10% sucrose, 0.1% CHAPS, 10 mM
DTT) supplemented with 500 μM DEVD-AMC (final concentration 50 μM) was added
to 10–25 μg of protein lysate. Caspase activity was assessed kinetically for 1 h (1 min
intervals) on a SpectraMax M2e plate reader (Molecular Devices, Sunnyvale, CA, USA).
Protein concentrations were measured by the BCA protein assay following the
manufacturer’s instructions (Thermo Fisher Scientific, Waltham, MA, USA).
qPCR analysis. Total RNA was isolated from 5 × 106 neutrophils using the SV
Total RNA Isolation System (Promega, Wallisellen, Switzerland) according to the
manufacturer’s instructions. RNA was reverse transcribed using oligo d(T) primers
and M-MLV reverse transcriptase (Promega) according to the manufacturer’s
instructions. Quantitative RT-PCR (qPCR) analysis was performed using HOT
FIREPol EvaGreen qPCR Mix Plus from Solis Biodyne (Tartu, Estonia) on a Real-
Time PCR machine (iQ5; Bio-Rad). Primer sequences were as follows: mmTnfα
(TNFα, amplicon 128 bp) – Fw, 5′-ATGAGAAGTTCCCAAATGGC-3′ and Rev,
5′-CACTTGGTGGTTTGCTACGAC-3′; reference gene mmHprt1 (HPRT, amplicon
124 bp) – Fw, 5′-TGGATACAGGCCAGACTTTGTT-3′ and Rev, 5′-CAGATTCAA
CTTGCGCTCATC-3′.
Fractionation by phase separation. A total of 0.5–2 × 107 neutrophils
were treated as indicated and further lysed in 0.5–1 ml Triton X-114 lysis buffer
(20 mM HEPES, pH 7.4, 150 mM NaCl, 2% Triton X-114, complemented with
protease inhibitors (Roche Complete protease inhibitor cocktail plus 1 μg/ml
pepstatin)) for 30 min on ice (adapted from Wang et al.59). Lysates were cleared by
centrifugation and further warmed at 30 °C for 3 min. Micelle-poor (Aq) and Micelle-
rich (Det) phases were obtained by centrifugation (1500 × g for 5 min at RT). Aq
phase was transferred to a new tube. Det phase was washed with a basal buffer
(20 mM HEPES, pH 7.4, 150 mM NaCl) and finally diluted with the basal buffer to
the same volume as the Aq phase. Proteins were denatured by adding 4 × Laemmli
buffer (supplemented with 100 mM DTT) and boiling for 5 min.
Statistical analysis. Data were analyzed using the Student’s t-test. All values
represent means± S.E.M. *Po0.05, **Po0.01, ***Po0.005 and ****Po0.001
were considered as statistically significant. Statistical analysis was performed using
the Prism 6 software (GraphPad, La Jolla, CA, USA).
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